‘We should not worry about mutations’

Virologists, scientists and health experts discuss novel coronavirus threadbare

Updated - February 23, 2021 11:43 am IST

Published - February 22, 2021 11:52 pm IST - Hyderabad

Delegates participating in a panel discussion as part of BioAsia2021 in the city on Monday.

Delegates participating in a panel discussion as part of BioAsia2021 in the city on Monday.

Acclaimed virologists and government officials, who participated in BioAsia-2021, said that they were not surprised that the novel coronavirus has mutated and that there are new strains of the virus. What is, however, is important is that there are the consequences of the new variants and its biological effect, they added.

The focus on the first day of the two-day BioAsia 2021 was Global Health and COVID-19. As part of it, virtual panel discussions on ‘Immunising the world’ and ‘COVID-19 – hits, misses, and hidden pandemic’ were held on Monday.

Speaking about the variants of coronavirus at the panel discussion on the latter subject, Peter Piot, director, London School of Hygiene and Tropical Medicine, said that, as virologists, they were not surprised. “That is what viruses do and they do it for a good reason from their perspective. They try to escape from anything that suppress it, be it our immune response or vaccines. That is why we have these variants and strains. We should not panic about various mutations. As we sequence more and more, we find more variants. However, there are some variants we have to be mindful of. When we sequence more and find mutations, we have to try find out what do they mean biologically,” Dr Piot said.

He further spoke about variants of the virus found in the United Kingdom, South Africa and Brazil, and the effect of vaccines on the variants. He said that the expectation from a vaccine is that it should protect people from ending up in hospitals, prevent deaths, and interrupt transmission.

Renu Swarup, secretary, Department of Biotechnology, spoke about the work being done during the pandemic such as establishing clinical trials network, pace of Indian clinical research and other aspects. V.G. Somani, Drugs Controller General (India), Richard Hatchett, chief executive officer of CEPI, and Naresh Trehan, chairman and managing director, Medanta Hospital, also participated in the panel discussion.

Speaking on ‘Immunising the World’, Chief Scientist at World Health Organisations (WHO) Sowmya Swaminathan said that they will come out with a standardised nomenclature for variants of interest and variants of concern.

Nivedita Gupta, scientist, Indian Council of Medical Research, spoke about the mechanism adopted to detect new variants of the virus entering the country. Regarding the surge in cases in Maharashtra and Kerala, she said that they are picking up samples from clusters and hotspots, and trying to sequence them.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.